Zevra Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
20.51 |
93.40 |
162.66 |
250.31 |
337.89 |
397.54 |
| Przychód Δ r/r |
0.00% |
355.44% |
74.14% |
53.89% |
34.99% |
17.65% |
| Przychód (min) |
20.06 |
83.76 |
114.60 |
247.01 |
276.23 |
325.00 |
| Przychód (max) |
20.76 |
100.30 |
231.99 |
253.61 |
416.72 |
490.30 |
| EBITDA (średnia) |
-15.11 |
-68.82 |
-119.85 |
-184.43 |
-248.96 |
-292.91 |
| EBIT (średnia) |
-15.23 |
-69.37 |
-120.81 |
-185.91 |
-250.95 |
-295.26 |
| EBIT % |
-74.27% |
-74.27% |
-74.27% |
-74.27% |
-74.27% |
-74.27% |
| Zysk netto (średni) |
-88.04 |
8.90 |
46.82 |
119.67 |
135.67 |
155.02 |
| Zysk netto % |
-429.27% |
9.53% |
28.78% |
47.81% |
40.15% |
38.99% |
| EPS (średnia) |
-1.89 |
0.19 |
0.63 |
1.79 |
2.93 |
3.35 |
| Liczba analityków (Przychody) |
6 |
5 |
8 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
6 |
6 |
8 |
6 |
3 |
4 |
| symbol |
ZVRA |
ZVRA |
ZVRA |
ZVRA |
ZVRA |
ZVRA |